Merck's CEO Richard Clark has unveiled plans to enter the biotech drug market by creating Merck BioVentures (MBV), a global division focused on developing biotech drugs, in particular copycat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback